SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 6, 2002, Pages 1734-1740

Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection

(13) Gish, R G a Leung, N W Y a Wright, T L a Trinh, Huy a Lang, W a Kessler, H A a Fang, L a Wang, L H a Delehanty, J a Rigney, A a Mondou, E a Snow, A a Rousseau, F a

a Triangle Pharmaceuticals (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; VIRUS DNA;

ABDOMINAL PAIN; ADULT; ANTIVIRAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; HEADACHE; HEPATITIS B; HUMAN; INFECTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VERTIGO; VIRUS LOAD; VIRUS REPLICATION;

ADOLESCENT; ADULT; ALGORITHMS; ANTIVIRAL AGENTS; AREA UNDER CURVE; COHORT STUDIES; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; VIRAL LOAD;

EID: 0036093269 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.46.6.1734-1740.2002 Document Type: Article

Times cited : (96)

References (14)

1
- 0028265233
- Evaluation of the potent antihepatitis B virus agent (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model
- (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 616-619
- Condreay, L.D.¹ Jansen, R.W.² Powdrill, T.F.³ Johnson, L.C.⁴ Selleseth, D.W.⁵ Paff, M.T.⁶ Daluge, S.M.⁷ Painter, G.R.⁸ Furman, P.A.⁹ Ellis, M.N.¹⁰ Averett, D.R.¹¹

2
- 0030754358
- In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks
- (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 2076-2082
- Cullen, J.M.¹ Smith, S.L.² Davis, M.G.³ Dunn, S.E.⁴ Botteron, C.⁵ Cecchi, A.⁶ Lindsey, D.⁷ Frick, L.⁸ Paff, M.T.⁹ Goudling, A.¹⁰ Biron, K.¹¹

3
- 0032874225
- Quantitation of intracellular triphosphate of emtricitabine in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients
- (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 2245-2250
- Darque, A.¹ Valette, G.² Rousseau, F.³ Wang, L.H.⁴ Sommadossi, J.-P.⁵ Zho, X.-J.⁶

4
- 0033592764
- Lamivudine as initial treatment for chronic hepatitis B in the United States
- (1999) N. Engl. J. Med. , vol.341 , pp. 1256-1263
- Dienstag, J.L.¹ Schiff, E.R.² Wright, T.L.³ Perrillo, R.P.⁴ Hann, H.-W.L.⁵ Goodman, Z.⁶ Crowther, L.⁷ Condreay, L.D.⁸ Woessner, M.⁹ Rubin, M.¹⁰ Brown, N.A.¹¹

5
- 0032835661
- Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy
- (1999) Hepatology , vol.30 , pp. 1082-1087
- Dienstag, J.L.¹ Schiff, E.R.² Mitchell, M.³ Casey D.E., Jr.⁴ Gitlin, N.⁵ Lissoos, T.⁶ Gelb, L.D.⁷

6
- 0032751727
- Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
- (1999) J. Infect. Dis. , vol.180 , pp. 1757-1762
- Gauthier, J.¹ Bourne, E.J.² Lutz, M.W.³ Crowther, L.M.⁴ Dienstag, J.L.⁵ Brown, N.A.⁶ Condreay, L.D.⁷

7
- 0032499913
- A one year trial of lamivudine for chronic hepatitis B
- (1998) N. Engl. J. Med. , vol.339 , pp. 61-68
- Lai, C.L.¹ Chine, R.W.² Leung, N.W.Y.³ Chang, T.T.⁴ Guan, R.⁵ Tai, D.I.⁶ Ng, K.Y.⁷

8
- 0033802362
- Long-term therapy of chronic hepatitis B with lamivudine
- (2000) Hepatology , vol.32 , pp. 828-834
- Lau, D.T.-Y.¹ Khokhar, M.F.² Doo, E.³ Ghany, M.G.⁴ Herion, D.⁵ Park, Y.⁶ Kleiner, D.E.⁷ Schmid, P.⁸ Condreay, L.D.⁹ Gauthier, J.¹⁰ Kuhns, M.C.¹¹ Liang, T.J.¹² Hoofnagle, J.H.¹³

9
- 0033754947
- Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy
- (2000) Hepatology , vol.32 , pp. 1145-1153
- Lok, A.S.-F.¹ Hussain, M.² Cursano, C.³ Margotti, M.⁴ Gramenzi, A.⁵ Grazi, G.L.⁶ Jovine, E.⁷ Benardi, M.⁸ Andreone, P.⁹

10
- 0034752631
- Prototype trial design for rapid dose selection of antiretroviral drugs: An example using emtricitabine (Coviracil®)
- (2001) J. Antimicrob. Chemother. , vol.48 , pp. 507-513
- Rousseau, F.S.¹ Kahn, J.O.² Thompson, M.³ Mildvan, D.⁴ Shepp, D.⁵ Sommadossi, J.-P.⁶ Delehanty, J.⁷ Simpson, J.N.⁸ Wang, L.H.⁹ Quinn, J.B.¹⁰ Wakeford, C.¹¹ Van der Horst, C.¹²

11
- 0027409698
- Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 875-881
- Schinazi, R.F.¹ Lloyd R.M., Jr.² Nguyen, M.-H.³ Cannon, D.L.⁴ McMillan, A.⁵ Iksoy, N.⁶ Chu, C.K.⁷ Liotta, D.C.⁸ Bazmi, H.Z.⁹ Mellors, J.W.¹⁰

12
- 0033761078
- Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B
- (2000) Hepatology , vol.32 , pp. 1078-1088
- Si Ahmed, S.N.¹ Tavan, D.² Pichoud, C.³ Berby, F.⁴ Stuyver, L.⁵ Johnson, M.⁶ Merle, P.⁷ Abidi, H.⁸ Trepo, C.⁹ Zoulim, F.¹⁰

13
- 0033012793
- Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B
- (1999) Hepatology , vol.29 , pp. 889-896
- Tassopoulos, N.C.¹ Volpes, R.² Pastore, G.³ Heathcote, J.⁴ Buti, M.⁵ Goldin, R.D.⁶ Hawley, S.⁷

14
- 0034888990
- Update on chronic viral hepatitis
- (2001) Postgrad. Med. J. , vol.77 , pp. 498-505
- Walsh, K.¹ Alexander, G.J.M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.